Matory Y L, Gaynor J, Brennan M
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Surg Gynecol Obstet. 1993 Oct;177(4):366-70.
We reviewed our experience with 69 patients with carcinoma of the ampulla of Vater admitted to the Memorial Sloan-Kettering Cancer Center, New York, from October 1983 to October 1990. Of the 69 patients, 66 were explored and 55 underwent resection (83 percent resectability). The median length of survival for the 55 patients who underwent resection was 51 months, compared with eight months for the 14 patients who did not undergo resection (p = 0.000004). Of the variables evaluated, only resectability was a statistically significant predictor of survival. Positive lymph nodes in 17 of 55 patients who underwent resection were not predictive of long term survival.
我们回顾了1983年10月至1990年10月间收治于纽约斯隆-凯特琳纪念癌症中心的69例 Vater壶腹癌患者的治疗经历。69例患者中，66例接受了探查，55例接受了手术切除（切除率为83%）。55例接受手术切除患者的中位生存期为51个月，而14例未接受手术切除患者的中位生存期为8个月（p = 0.000004）。在所评估的变量中，只有可切除性是生存期的统计学显著预测因素。55例接受手术切除患者中有17例出现阳性淋巴结，这并非长期生存的预测因素。
